INSIGHTS ON CLINICAL TRIAL DESIGN
-
![human-heart-cardiac]( "Cardiac Safety Assessments In Clinical Trials")
Cardiac Safety Assessments In Clinical TrialsAssess cardiac risk with expert QT/QTc study design and execution, generating reliable data to inform decisions, reduce development risk, and keep your program moving forward.
-
![How Adaptive Design Accelerates Early Phase NSCLC Development]( "How Adaptive Design Accelerates Early‑Phase NSCLC Development")
How Adaptive Design Accelerates Early‑Phase NSCLC DevelopmentAdaptive trial designs and an adaptive mindset enable non-small cell lung cancer (NSCLC) sponsors to optimize dose, respond to evolving expectations, and accelerate early‑phase development.
-
![GettyImages-1719538555 in home nurse visit patient]( "5 Common Misconceptions About Mobile Visits In Clinical Trials")
5 Common Misconceptions About Mobile Visits In Clinical TrialsIn this article, we address five key misconceptions about mobile research services, including concerns about inconsistent nurse assignments, privacy risks, and limited applications for complex protocols.
-
![early-oncology-trials-GettyImages-1796958784]( "Unanticipated Roadblocks In Ovarian Cancer Drug Development")
Unanticipated Roadblocks In Ovarian Cancer Drug DevelopmentEnhance your Ovarian cancer trials by enabling community referral pipelines, aligning imaging with biomarker assessments, and selecting sites based on verifiable surgical capacity.
-
Accelerating Enrollment And Upholding Quality In Complex Oncology Trials5/5/2026
Real-world oncology trials reveal how fast physician engagement, hands-on biomarker management, and adaptive enrollment shorten timelines, reach first-patient milestones, and preserve data quality.
-
Mid-Study Randomization: Ensuring Data Integrity In Oncology Trials7/5/2026
Miscommunication between supply chain vendors risks costly delays. Discover how unifying physical and digital operations catches issues before they disrupt a trial.
-
From Bottlenecks To Breakthroughs: How AI Is Transforming Translation Timelines9/12/2025
Take a deeper look at AI-enabled translations and uncover how they are able to drive a remarkable 43% reduction in overall translation timelines.
-
How A Small Biotech Partnered With Us To Navigate Trial Complexity With Confidence And Control7/30/2026
Early-phase trials often evolve rapidly. See how a flexible RTSM approach helped a biotech sponsor manage major protocol changes without disrupting study execution.
-
Human Abuse Potential: Selecting A Positive Control5/8/2026
Choosing an effective positive control in HAP studies is critical but not always straightforward. Learn how to justify comparator and dose selection.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![clinical-trials-tech-GettyImages-2224526089]( "TrialKit AI: Intelligence For Clinical Trials")
Design, build, simulate, and analyze clinical studies in one connected system. Embedded intelligence supports the full lifecycle, from protocol development to closeout.
-
![GettyImages-1034029812-casual-calculator-calculate]( "What Is Tru's Live Clinical Execution Worth To Your Trial")
Plug in your trial details and see the impact of live data capture on queries, timelines, and source data quality.
-
![GettyImages-2189405678-GLP-1-obesity]( "Precision Partnership For Obesity Clinical Trials")
Accelerate obesity research with specialized expertise in GLP-1 trials. Our approach ensures rapid enrollment, high participant retention, and clean data through a patient-centered model.
-
![Website]( "Orchestrated Study Start-Up")
Learn how the IQVIA Investigator Site Portal reduces activation timelines and eliminates site frustrations by automating processes and providing complete oversight to study teams.
-
![GettyImages-1254825733 data]( "Simulants: Unlock Insights And Accelerate Medical Breakthroughs")
Get an overview of this groundbreaking synthetic data product – uniquely derived from Medidata’s exclusive repository of global, standardized historical clinical trial data.
